FOR AUTHORS
Manuscript Preparation
To expedite the review process, please format the manuscript in the following way:
Manuscript organization:
1. All manuscripts are expected to be prepared as a single PDF or MS Word document with the complete text, references, tables and figures included. Any revised manuscripts prepared for publication should be sent as a single editable Word document. LaTex paper is also acceptable for publication, but it should be in PDF for review first.
2. Manuscripts should be written in English. Title, author(s), and affiliations should all be included on a title page as the first page of the manuscript file, followed by a 100-300 word abstract and 3-5 keywords. The order they follow is: Title, Authors, Affiliations, Abstract, Keywords, Introduction.
Figure and table requirement:
3. All figures or photographs must be submitted as jpg or tif files with distinct characters and symbols at 500 dpi (dots per inch). Test your figures by printing them from a personal computer. The online version should look relatively similar to the personal-printer copy. Tables and equations should be in an editable rather than image version. Tables must be edited with Word/Excel. Equations must be edited with Equation Editor. Figures, tables and equations should be numbered and cited as Figure 1, Figure 2, Figure 3, etc. in sequence.
templates to prepare the final manuscript
本刊可以接受中文稿件，但需包括英文題目、摘要、關鍵詞，來稿應能反映國內外領域的最新研究動態和研究結果。題文相符，論點明確，論據可靠，數據準確，文字簡明規範。具體要求如下：
1. 來稿應包括封面頁和正文
封面頁包括題目（中英文）、作者（中英文）、作者簡介（中文，100字以內）、所屬單位（中英文）、通訊地址、電話和Email地址等。
正文包括題目、摘要（中英文）、關鍵詞（中英文）、引言、方法、結果、討論、結論和參考文獻等部分內容。（不要包含作者姓名、單位等作者信息）
來稿（包括圖表、參考文獻），以5000－8000字爲宜。
2. 題目、摘要和關鍵詞
題目簡潔明瞭，字數一般不超過30字。
摘要應包括目的、方法、結果和結論四個部分，其中中文摘要約300字，英文摘要約600-800字。
關鍵詞3至7個（中英文）。
3. 正文
正文是文章的主體部分，應內容充實、邏輯清晰、表述規範。
請使用法定計量單位、符號以及標準化、規範化的名詞和術語。
中文稿件模板：https://erytis.com/web/assets/images/home/erytis+word_template+CN.docx
所投稿件需保證文章版權的獨立性，文責自負，勿一稿多投。
1. 來稿應包括封面頁和正文
封面頁包括題目（中英文）、作者（中英文）、作者簡介（中文，100字以內）、所屬單位（中英文）、通訊地址、電話和Email地址等。
正文包括題目、摘要（中英文）、關鍵詞（中英文）、引言、方法、結果、討論、結論和參考文獻等部分內容。（不要包含作者姓名、單位等作者信息）
來稿（包括圖表、參考文獻），以5000－8000字爲宜。
2. 題目、摘要和關鍵詞
題目簡潔明瞭，字數一般不超過30字。
摘要應包括目的、方法、結果和結論四個部分，其中中文摘要約300字，英文摘要約600-800字。
關鍵詞3至7個（中英文）。
3. 正文
正文是文章的主體部分，應內容充實、邏輯清晰、表述規範。
請使用法定計量單位、符號以及標準化、規範化的名詞和術語。
中文稿件模板：https://erytis.com/web/assets/images/home/erytis+word_template+CN.docx
所投稿件需保證文章版權的獨立性，文責自負，勿一稿多投。
Disclosure instructions
Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’.
Statement: During the preparation of this work the author(s) used [NAME TOOL/SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
This declaration does not apply to the use of basic tools for checking grammar, spelling, references etc. If there is nothing to disclose, there is no need to add a statement.
Plagiarism, Data Fabrication, and Image Manipulation
Erytis Publishing Limited upholds the highest standards of academic integrity and strictly prohibits any form of plagiarism, data fabrication, and image manipulation. We expect authors to adhere to these ethical principles in all aspects of their research and writing process.
Plagiarism includes copying text, ideas, images, or data from another source, including the author's own previously published works, without properly attributing the original source. All sources must be cited where they are used in the text. If a manuscript's design, language, or structure has been influenced by previous works, these must be explicitly referenced. Reused text from another source should be enclosed within quotation marks, with the original source correctly cited.
Data presented in any submission must be original. Any form of data fabrication, selective representation of results, enhancement, or inappropriate manipulation will not be tolerated. This includes, but is not limited to, exclusion of data points to falsely enhance the significance of conclusions, deliberate selection of analysis tools to support a particular conclusion, or the fabrication of data.
Image files must be presented as they are and must not be adjusted or manipulated in any way that could lead to misinterpretation of the information provided by the original image. Any manipulation, such as introduction, enhancement, removal of features from the original image, inappropriate grouping of images, or altering the contrast, brightness, or color balance to obscure or enhance certain information, is not acceptable.
If irregular image manipulation or data fabrication is identified during the peer review process, the manuscript may face rejection. If such issues are discovered after publication, appropriate measures including corrections or retractions may be taken in line with our policies.
Conflicts of interest
Conflicts of interest, such as research grants, paid or unpaid personal or institutional relationships, or personal relationships with individuals involved in the article publication process, must be declared at the end of the manuscript. Plagiarism (as well as self-plagiarism) is not acceptable. Considered plagiarism is word-for-word copying and using ideas or concepts of someone else without correct citation of the source. False data (invented or modified) are not acceptable.
Research on humans
Experimental research on humans must have been approved by an appropriate ethics committee and comply with the Helsinki Declaration (2013). Participants of a study included in a manuscript are protected and should not be identifiable. It is, therefore, the responsibility of the authors to remove any identifying information of their study subjects, such as clinical images and videos, names, personal and health data, details, etc., that could allow for identifying the person. Informed consent must be documented in the manuscript where information or clinical photographs of human subjects are used. Signed copies of consent forms will be required before a paper can be considered for review.
Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.
Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans, as outlined in Elsevier’s AI policy for authors.
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.
Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans, as outlined in Elsevier’s AI policy for authors.
Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process by following the instructions below. A statement will appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.
Corrections and Retractions
Erytis Publishing Limited understands the importance of maintaining the integrity of published research. If any suspicion of misconduct or alleged fraud arises, the journal will initiate an investigation following the COPE guidelines. Depending on the findings, the following actions might be taken:
1.If the manuscript is still under consideration, it may be rejected and returned to the author.
2.If the article has been published online, the response will depend on the nature and severity of the issue:
A correction or erratum may be placed with the article for minor errors that do not affect the scientific understanding of the work.
An editor's note or editorial expression of concern may be placed with the article if there are significant issues affecting the integrity of the work.
In severe cases, retraction of the article may occur. A retracted article will be marked as "retracted" and the reasons for retraction will be detailed in a note linked to the article.
3.The author's institution may be informed about the issue.
4.A note may be added to the author's and the article's bibliographic record indicating the suspected breach of ethical standards.
Removal of Published Content
In exceptional circumstances, Erytis Publishing Limited reserves the right to remove an article from our online platforms. Such action will be taken if the content is defamatory, infringes on third-party rights, or poses a serious health risk. The removal can be temporary or permanent. The bibliographic metadata (e.g., title and authors) will remain and will be accompanied by a statement explaining why the content has been removed.
Metadata errors such as errors in the title, author's name, or abstract can be corrected. After the correction is approved, the article will be updated and republished on our website, and all relevant indexing databases will be notified.
In some cases, an article may need to be retracted due to serious errors, gross ethical breaches, data fabrication, significant plagiarism, or other reasons. Such actions are taken to protect the integrity of the scientific record. Erytis Publishing Limited adheres to the COPE guidelines for retractions.
Article Processing Charge
Authors are asked to pay an article processing charge (APC) of $200 US dollars per processed paper.
Rejected articles are free of charge. There are no surcharges based on the length of an article, figures or supplementary data.
Waivers may be considered on a case-by-case basis, taking into account the quality of the research article and the authors' financial need.
Authors are asked to pay an article processing charge (APC) of $200 US dollars per processed paper.
Rejected articles are free of charge. There are no surcharges based on the length of an article, figures or supplementary data.
Waivers may be considered on a case-by-case basis, taking into account the quality of the research article and the authors' financial need.
Confidentiality
At Erytis Publishing Limited, we are committed to upholding the highest standards of confidentiality in the handling of manuscripts. This means all details pertaining to a submitted manuscript, including its review status and the details of its review, are kept confidential. We do not publicize or comment on submitted or rejected manuscripts.
All participants in the publication process - including authors, reviewers, and editors - are expected to treat all communication with Erytis Publishing Limited as confidential. This includes correspondence with representatives from the journal, such as editors-in-chief, handling editors, and the content of reviewers’ reports, unless explicit consent has been received to share this information.
However, there may be instances where we need to share materials with relevant parties. This would be the case if there are allegations of misconduct and an investigation is required. In such instances, we would do so in compliance with our responsibilities to uphold the integrity of academic publishing. All parties are expected to respect this confidentiality policy and understand the important role it plays in the peer review and publication process.
At Erytis Publishing Limited, we are committed to upholding the highest standards of confidentiality in the handling of manuscripts. This means all details pertaining to a submitted manuscript, including its review status and the details of its review, are kept confidential. We do not publicize or comment on submitted or rejected manuscripts.
All participants in the publication process - including authors, reviewers, and editors - are expected to treat all communication with Erytis Publishing Limited as confidential. This includes correspondence with representatives from the journal, such as editors-in-chief, handling editors, and the content of reviewers’ reports, unless explicit consent has been received to share this information.
However, there may be instances where we need to share materials with relevant parties. This would be the case if there are allegations of misconduct and an investigation is required. In such instances, we would do so in compliance with our responsibilities to uphold the integrity of academic publishing. All parties are expected to respect this confidentiality policy and understand the important role it plays in the peer review and publication process.
